Showing results for:
Drug name(s)
Exjade® Jadenu® Deferasirox
Approved for
- Other Blood Cancers
Drug name(s)
Rolvedon™ Eflapegrastim-xnst
Approved for
- Other Blood Cancers
Drug name(s)
Empliciti™ Elotuzumab
Approved for
- Myeloma
Drug name(s)
Elranatamab-bcmm
Approved for
- Myeloma
Drug name(s)
Idhifa® Enasidenib
Approved for
- Leukemia
- Acute Myeloid Leukemia (AML)
Drug name(s)
Epcoritamab-bysp Epkinly®
Approved for
- Large B-Cell Lymphoma (LBCL)
- Lymphoma
- Non-Hodgkin Lymphoma (NHL)
- Diffuse Large B-cell Lymphoma (DLBCL)
- Follicular Lymphoma (FL)
Drug name(s)
Epogen® Procrit® EPO Epoetin alfa Epoetin alfa-epbx* Retacrit™ *
Approved for
- Other Blood Cancers
Drug name(s)
Etopophos® Toposar® VePesid® VP-16 Etoposide
Approved for
- Lymphoma
- Hodgkin Lymphoma (HL)
- Non-Hodgkin Lymphoma (NHL)
Drug name(s)
Evomela™ Melphalan hydrochloride
Approved for
- Myeloma
Drug name(s)
Elitek® Rasburicase
Approved for
- Leukemia
- Lymphoma
Drug name(s)
Elzonris™ Tagraxofusp-erzs
Approved for
- Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)